Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 1,022.00
-14.20 (-1.37%)
Oct 7, 2026, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 21.09 billion as of October 7, 2026. That makes Windlas Biotech the world's 20,419th most valuable company and 1,246th in India. Its market cap has increased by 9.24% in one year.
Market Cap
21.09B
Enterprise Value
18.65B
Revenue
9.42B
Global Rank
Country Rank
#1,246 India
PE Ratio
33.29
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 21.09B, an increase of 137.67%. That is a compound annual growth rate of 18.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 21.09B | 26.56% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 48.99B |
| RPG Life Sciences | 47.90B |
| Ind-Swift Laboratories | 33.55B |
| Solara Active Pharma Sciences | 32.66B |
| Indoco Remedies | 23.24B |
| Sakar Healthcare | 22.40B |
| Beta Drugs | 20.31B |
| Anlon Healthcare | 16.59B |